The Week In... Medical Devices (07-11/10)
  • Posted on: 11/10/2019
  • Category: Industry

The Week In... Medical Devices (07-11/10)

An innovation that combines data analytics and wearable technology to prevent falls is shortlisted in an awards category, the Axis-D pen-injector tech is to be licensed for development in diabetes treatment, and Northern Ireland’s Stormont is given £31m to prepare for a no-deal Brexit. 

Interested in Star’s innovative outsourcing and resourcing solutions? 

Contact Operations Director, Mark Ward, on 07872 105 540 or email mark.ward@starmedical.co.uk.   

On the hunt for a new role, or just curious? 

Visit our candidate page, submit your CV to candidates@starmedical.co.uk, or give our offices a ring! 

Device developer and packaging producer agree to license pen-injector

Self-injection device developer Haselmeier, and glass packaging producer Stevanato Group has announced an agreement to license the Axis-D pen-injector technology and intellectual property (IP) for development, manufacturing and supply of the Axis-D pen-injector in diabetes care.

Six steps life science firms can take to get ready for Brexit

The UK will be leaving the EU on 31 October. This will bring important changes to doing business. Here are six things life science companies can do now to get ready.

Brexit: Stormont given £31m to prepare for no deal

Northern Ireland's Department of Finance was given £31.4m during the summer to help Stormont departments prepare for a no-deal Brexit.

Falls prevention technology shortlisted for award

Shortlisted in the Innovation in TEC Award category, ARMED (Advanced Risk Modelling for Early Detection), developed by HAS Technology, combines data analytics modelling with wearable technology.

How advances in sensing and monitoring tech could revolutionise care

Nigel Whittle, head of healthcare & medical at Plextek, outlines where and how advances in health sensing and monitoring tech could help start to revolutionise our care.

While you’re here…

…and are interested in our content, why not sign up to our newsletter? It’s just below here.